Harmony Biosciences Holdings annual debt-to-assets ratio
2019
2020
2021
2022
2023
2024
2025
Harmony Biosciences Holdings Debt-to-Assets Ratio Growth & History (HRMY)
Harmony Biosciences Holdings's debt-to-assets ratio was 0.13 for fiscal 2025.
View full Harmony Biosciences Holdings company overviewHarmony Biosciences Holdings annual debt-to-assets ratio history
| Fiscal year | Period ended | Debt-to-assets ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.13 | −0.05 | −26.69% |
| 2024 | 2024-12-31 | 0.18 | −0.06 | −24.87% |
| 2023 | 2023-12-31 | 0.24 | −0.05 | −16.16% |
| 2022 | 2022-12-31 | 0.29 | −0.16 | −36.17% |
| 2021 | 2021-12-31 | 0.45 | −0.00 | −0.71% |
| 2020 | 2020-12-31 | 0.45 | −0.46 | −50.45% |
| 2019 | 2019-12-31 | 0.92 | — | — |
Harmony Biosciences Holdings quarterly debt-to-assets ratio
Q4.19
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Debt-to-assets ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.12 | −0.04 | −25.44% |
| Q1 2026 | 2026-03-31 | 0.13 | −0.04 | −23.02% |
| Q4 2025 | 2025-12-31 | 0.13 | −0.05 | −26.69% |
| Q3 2025 | 2025-09-30 | 0.14 | −0.06 | −29.61% |
| Q2 2025 | 2025-06-30 | 0.16 | −0.06 | −28.96% |
| Q1 2025 | 2025-03-31 | 0.17 | −0.06 | −26.24% |
| Q4 2024 | 2024-12-31 | 0.18 | −0.06 | −24.87% |
| Q3 2024 | 2024-09-30 | 0.20 | −0.06 | −22.27% |
| Q2 2024 | 2024-06-30 | 0.22 | −0.03 | −13.57% |
| Q1 2024 | 2024-03-31 | 0.23 | −0.04 | −16.06% |
| Q4 2023 | 2023-12-31 | 0.24 | −0.05 | −16.16% |
| Q3 2023 | 2023-09-30 | 0.26 | −0.05 | −15.14% |
| Q2 2023 | 2023-06-30 | 0.25 | −0.13 | −34.05% |
| Q1 2023 | 2023-03-31 | 0.27 | −0.15 | −35.53% |
| Q4 2022 | 2022-12-31 | 0.29 | −0.16 | −36.17% |
| Q3 2022 | 2022-09-30 | 0.30 | −0.19 | −38.39% |
| Q2 2022 | 2022-06-30 | 0.39 | −0.16 | −28.94% |
| Q1 2022 | 2022-03-31 | 0.42 | −0.16 | −27.12% |
| Q4 2021 | 2021-12-31 | 0.45 | −0.00 | −0.71% |
| Q3 2021 | 2021-09-30 | 0.49 | −0.11 | −18.49% |
| Q2 2021 | 2021-06-30 | 0.54 | — | — |
| Q1 2021 | 2021-03-31 | 0.58 | — | — |
| Q4 2020 | 2020-12-31 | 0.45 | −0.46 | −50.45% |
| Q3 2020 | 2020-09-30 | 0.60 | — | — |
| Q4 2019 | 2019-12-31 | 0.92 | — | — |
Harmony Biosciences Holdings debt-to-assets ratio trends
Over the last five fiscal years, Harmony Biosciences Holdings's debt-to-assets ratio decreased from 0.45 to 0.13, a change of −0.32. The latest reported quarter, Q2 2026, shows 0.12.
About the metric
What the debt-to-assets ratio means
The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.
Calculation and source
How debt-to-assets is calculated
TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Harmony Biosciences Holdings source filings ↗